These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17711381)

  • 1. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.
    Altice FL; Mezger JA; Hodges J; Bruce RD; Marinovich A; Walton M; Springer SA; Friedland GH
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S376-87. PubMed ID: 15156426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Lucas GM; Mullen BA; Weidle PJ; Hader S; McCaul ME; Moore RD
    Clin Infect Dis; 2006 Jun; 42(11):1628-35. PubMed ID: 16652321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
    Lucas GM; Weidle PJ; Hader S; Moore RD
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S409-13. PubMed ID: 15156431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.
    Altice FL; Maru DS; Bruce RD; Springer SA; Friedland GH
    Clin Infect Dis; 2007 Sep; 45(6):770-8. PubMed ID: 17712763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.
    Babudieri S; Dorrucci M; Boschini A; Carbonara S; Longo B; Monarca R; Ortu F; Congedo P; Soddu A; Maida IR; Caselli F; Madeddu G; Rezza G
    AIDS Patient Care STDS; 2011 Jun; 25(6):359-64. PubMed ID: 21612546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.
    Maru DS; Bruce RD; Walton M; Springer SA; Altice FL
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):176-81. PubMed ID: 19131891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.
    Sorensen JL; Haug NA; Larios S; Gruber VA; Tulsky J; Powelson E; Logan DP; Shapiro B
    J Subst Abuse Treat; 2012 Dec; 43(4):418-23. PubMed ID: 23007110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic.
    Purkayastha T; Wasi F; Shuter J
    AIDS Patient Care STDS; 2005 Dec; 19(12):785-93. PubMed ID: 16375610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.
    Nachega JB; Stein DM; Lehman DA; Hlatshwayo D; Mothopeng R; Chaisson RE; Karstaedt AS
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1053-6. PubMed ID: 15585095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
    Gianotti N; Soria A; Galli L; Castagna A; Cernuschi M; Hasson H; Lazzarin A
    J Med Virol; 2004 Feb; 72(2):181-6. PubMed ID: 14695657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.
    Smith-Rohrberg D; Mezger J; Walton M; Bruce RD; Altice FL
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S48-53. PubMed ID: 17133204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
    van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W
    J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations.
    Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C
    HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.